Annual Report - FIP

Annual Report
200 7
8

Annual Report
200 7
8

2
Annual Report
200 7
8
Contents
Year Overview...................................................................................................................3
GPP - Good Pharmacy Practice Project Report.............................................................5
Congress Travel Grant Award Reports...........................................................................8
Medicines Information to Children and their Carers ..................................................17
Foundation Supporters' Club .......................................................................................20
Finance............................................................................................................................21
Information ....................................................................................................................23

Objectives
Year Overview
The Foundation's objectives are to promote the education of and research by pharmacists and
pharmaceutical scientists within the general fields of design, manufacture, distribution and use of
medicines for humans and/or animals.
Board of Managing Directors
In 2007 two meetings were scheduled (February and September). The first meeting took place on 27
February in Basel, Switzerland. The second meeting took place on 4 September in Beijing, People's
Republic of China.
Chairman Dr P. Kielgast, Denmark
Executive Director Mr A.J.M. Hoek, The Netherlands
Director Ms O. Barra, UK
Director Mr T. Björk, Sweden
Director Ms M.L. Hsiao, Taiwan
Director Prof. H.R. Manasse, Jr., USA
Director Mr M. Rouse, USA
Director Dr V.P. Shah, USA
As of 7 September 2007 Dr. L. Z. Benet (USA) became the new Chairman of the FIP Foundation for
Education and Research.
Congress Travel Grants
The Foundation Board awards a limited number of Congress Travel Grants on an annual basis to enable
pharmacists and/or pharmaceutical scientists to attend the FIP congress. The aim of the Congress
Travel Grants is to allow recipients to travel to the FIP congress in order to develop, or to help others
to develop, skills and/or knowledge in line with the objectives of the Foundation. The Executive
Committees of the FIP Regional Pharmaceutical Forums will be acting as Regional Evaluation
Committees. The successful grant applications will be equally spread amongst the 6 FIP Regional
Forums, with a maximum of two grant winners per forum.
The Foundation Board of Directors decided to grant 10 Congress travel grants in 2007. The following
grant awardees were able to attend the FIP Congress in Beijing:
African:
Ms Jocelyn M. Chaibva, Zimbabwe
Mr William Etubiebi, Nigeria
3
Annual Report
200 7
8

4
Annual Report
200 7
8
Americas:
Mr Guido Paulo Arturo Cáceres, Argentina
EuroPharm Forum:
Ms Maja Ortner Hadziabdic, Croatia
Ms Corina Ursu, Rep. Of Moldova (She could not attend the Congress in 2007, but will attend next year's
Congress in Basel, Switzerland)
South East Asia:
Dr Subhash C. Mandal, India
Ms Ganga Senarathna, Sri Lanka
Western Pacific:
Ms Dinh Thi Thanh Thuy, Vietnam
Eastern Mediterranean:
Ms Hagar I. Labouta, Egypt
Mr Syed Shamim Raza, Pakistan
In 2007, for the 14 th time, the FIP Foundation for Education and Research had a booth in the noncommercial
exhibition area during the FIP annual Congress. Once again, the stand was combined with
the FIP booth and proved to be a great success, especially with the help of the Board of Directors.
FIP Young Pharmacist/Pharmaceutical Scientist Award for Professional Innovation
This award is given on an annual basis to a young pharmacist or pharmaceutical scientist. Its aims are
to promote innovation in the profession of pharmacy and pharmaceutical sciences through creative
projects addressing a specific issue or problem within a field of professional practice or pharmaceutical
sciences. The project's outcome should have a positive impact on the community.
In 2007 the FIP Young Pharmacist/Pharmaceutical Scientist Award for Professional Innovation was
awarded to:
Dr Christie Robinson, USA
Guidelines for the Grants and Awards Programme
The Board has developed detailed Guidelines for each of the classes of Awards and Grants. These can
be obtained from the Executive Director of the FIP Foundation or on the web site: www.fip.org/foundation.

GPP - Good Pharmacy
Practice Project Report
Comprehensive pharmacy service involves activities both to secure good health and to avoid ill-health
in the population. When ill-health is treated, it is necessary to assure quality in the process of using
medicines in order to achieve maximum therapeutic benefit and avoid untoward side-effects 1 . The
concept of collaboration between pharmacists and other healthcare professionals and pharmacists being
accountable for positive patient outcomes should be at the heart of all good pharmacy practices (GPP).
GPP aims to define appropriate, legal, ethical practices; strengthen regulatory control; improve access
to medicines that are safe, appropriate, and cost-effective and of optimum pharmaceutical quality;
ensure rational use of medicines and thus ultimately optimise patient outcomes. GPP encourages the
development of standards and regulation for elements of pharmaceutical services relating to the
promotion of health, supply of medicines and medical devices, patient self-care, and prescribing and
medicines use. In order to implement GPP, pharmacy personnel need to be competent for practice
and be supported by professional and regulatory bodies.
Standards on the supply and use of medicines should be defined for elements which include medication
records, competence of pharmacy personnel, storage and medicine's pharmaceutical quality, patient
follow up and monitoring, formularies and treatment guidelines, assessment of drug promotion
materials, reporting of adverse effects/errors/defects in medicine's pharmaceutical quality/counterfeit.
Whilst GPP does not define global minimum standards of practice - these need to be developed for
specific country contexts and needs - they provide a framework to guide professional and regulatory
processes to enable systematic implementation. These may also lead to the set up of accreditation
systems for pharmacies to ensure adherence to GPP.
All practicing pharmacists are obliged to ensure that the service they provide to every patient is of an
appropriate quality. Good pharmacy practice is a means of meeting that obligation. Thus, with the
overall aim to improve standards and practice of drug distribution and drug utilization, using the
FIP/WHO Guidelines for Good Pharmacy Practice (GPP) as the framework, the International
Pharmaceutical Federation (FIP) had taken the initiative to explore the possibilities for providing
technical assistance to Member Organisations in Thailand, Uruguay, Vietnam, Moldova, Mongolia,
Paraguay and Cambodia in developing national standards for GPP, in a pilot study from 2005 to 2007.
The pilot project is now completed and this report serves to identify key positive learning outcomes
from the experience and to provide policy guidance for future projects in GPP.
The FIP Bureau concluded that the GPP Pilot project was a very positive experience for those countries
selected for the project implementation as well as those who were involved as observers. It brought
Good Pharmacy Practice to the attention of high-level policy makers and fostered cooperation among
?????
1. FIP Statement on Quality of Pharmacy Services (September 1997)
5
200 Annual Report
7
8

6
Annual Report
200 7
8
decision makers within countries. In Thailand, a 1st Regional Conference on GPP Policy and Plans in
South East Asia was organised by SEARPharm Forum and the GPP project secretariat at the Thai Food
and Drug Administration, supported by WHO SEARO and WPPForum, for representatives from
authorities and professional organisations in 13 countries. The first outcome of this conference was a
joint initiative by the national office of WHO in India and SEARPharm Forum to organise a "National
Conference on Challenges and Opportunities for Pharmacists in Health Care in India".
The pilot project had also created acceptance of FIP and GPP in the host countries. FIP had been invited
to lead various national pharmaceutical conferences in Paraguay, Chile, Thailand and Uruguay. Training
workshops in implementing national strategies on GPP have been successfully conducted with good
feedback from the participants in Denmark, Thailand, Vietnam and Uruguay. In addition to FIP
facilitated study tours in Denmark, Portugal and Spain, these catalysed numerous processes by which
the rational use of medicines was improved so that health can be improved and/or maintained within
these countries.
Notably, the FIP Western Pacific Pharmaceutical Forum has been involved in supporting the writing
of the new GPP statutes in Vietnam and arranging supporting education programs in the country.
The GPP statutes complete the total restructure of pharmacy and the pharmaceutical industry in
Vietnam, having already established new international standards for good manufacturing practice and
good distribution practice. On 23rd February of 2008, the Ministry of Health issued instructions to
boost the application of Good Pharmacy Practices (GPP) standards for all drugstores nationwide. Under
the ministry's regulation, all drugstores of hospitals and drug companies must meet GPP standards
by 2011 to remain in operation and other drugstores by 2013. By June 2008, all companies that own
drugstore chains must each have at least one drugstore meeting GPP standards set by the ministry.
With these positive experiences, the FIP Bureau has also made a set of recommendations for future
projects of such nature.
The FIP Bureau sees a role for FIP, the FIP-Foundation, the Forums and local pharmaceutical
organisations to work collaboratively and synergistically with local and regional organisations to
implement FIP policy, including GPP. The role of FIP in improving the rational use of medicines and
improving and maintaining health could be enhanced in the following ways:
? Policy development
? Creating consistency, continuity and solidarity globally
? Providing limited "seed grants" to support local and regional initiatives
? Providing expertise when needed as a catalyst for implementation at the local and regional level
? Providing an opportunity for education, training, and networking at the FIP Congresses
? Raising the importance of policy issues to financing agents such as WHO and the World Bank
Local and regional organisations also have a role in improving the rational use of medicines by working
with FIP to implement FIP policy including GPP. This collaboration can have advantages such as:
? Lower costs when programmes are coordinated and implemented within local and regional
organizations;

? Interest, responsiveness to the local situation, ownership and sustainability are more likely if policy
implementation occurs at the local and regional level;
? Changes in practice require changes in attitude that also must come from local and regional
leadership over a long period of time.
In conclusion, the technical support FIP has provided in this three year pilot project has enhanced the
progress of the implementation of WHO/FIP policies and guidelines on good pharmacy practice. It
is a firm belief that the project countries are committed to continuing these efforts, however the speed
of the process and the results strongly depend on the availability of international networking and
support 2 .
?????
2. FIP report on Technical assistance to the implementation of WHO/FIP Guidelines on Good Pharmacy Practice
in countries with developing economies (August 2007)
7
200 Annual Report
7
8

8
Annual Report
200 7
8
Congress Travel Grant
Award Reports
Report on participation at 67th International Congress of FIP, Beijing, China 2007
By
Hagar Ibrahim, Alexandria, Egypt
2007 FIP Congress Travel Grant Awardee
My name is Hagar Ibrahim. I work as a lecturer assistant at the Faculty of Pharmacy, University of
Alexandria, Egypt. I was one of the recipients of FIP travel grants for attending the 67 th International
Congress of FIP at Beijing, China 2007.
I was really impressed by the outstanding scientific climate and the friendly environment during the
congress days. The sessions were given by well-recognized speakers. Some of these sessions were
relevant to my area of specialization, for instance, the talk on the regulations and the specifications for
in vitro testing of novel dosage forms by Dr Cynthia Brown, a research-based talk on lipid-based
formulations for enhancing the solubility of poorly soluble drugs by Dr Chris Porter, Dr Pauletti's talk
on the use of nanocarriers for gene delivery, "industrial nanomanufacturing of drug delivery systems"
by Dr Kawashima, the talk by Dr Zhang Qiang from University of Beijing on nanoparticulate formulations
and others. This was of outmost importance in terms of valuable information, latest pharmaceutical
trends through the presentations and through answering questions, asked by me or by other participants,
which they highly encouraged and responded to. The congress was also a chance for direct contact with
these great scientists, to benefit from their experience and meet other young researchers from all around
the globe and explore some ideas with them. The congress has also allowed me to make good friends
like Dr Sandra Klein from University of Frankfurt, Germany and Dr Cheng Tong working at Pfizer
at the USA.
Besides this, I presented part of my work completed during my master program as an oral presentation
in the industrial pharmacy section of the congress. The presentation was entitled "Verapamil hydrochloride
microspheres for potential topical applications" and it was acknowledged by the present professors,
scholars and colleagues. This was a great experience for me knowing that this was the first time for
me to give a podium presentation in a conference.
Moreover, there was also a room to attend sessions of other sections especially the session on "The use
of informatics to improve medication safety" which included very interesting and interactive talks.
Finally, attending the congress has achieved my objectives in terms of valuable and updated scientific
information, building relationships with others and enhancing my personal development. The experience
gained through attending such a successful congress will positively affect my research work aiming
for influencing pharmaceutical industry at my home country, Egypt. This will also allow me to take
more active role in my society through passing the experience and knowledge I got to my colleagues

and to the undergraduate students, encouraging them to attend international congresses such as the
FIP.
Such a great experience wouldn't have become possible if not for the travel grant from the FIP foundation.
These grants are of outmost importance for young researchers like me in the developing countries. For
that, I would like to thank the FIP for giving me the chance to present my work and enhance my skills
and knowledge, with FIP financial assistance, at the 67 th International Congress of FIP.
Report on participation at 67th International Congress of FIP, Beijing, China 2007
By
Dr. Subhash C. Mandal, M.Pharm., Ph.D (Pharm.), India
2007 FIP Congress Travel Grant Awardee
It is my proud privilege to report that I have attended the World Congress of Pharmacy and Pharmaceutical
Sciences 67 th International Congress of FIP held at Beijing, China during 31 st August - 6 th September
2007 and presented a paper. This was possible due to the Travel Grant offered to me by the FIP
Foundation for Education and Research.
I have presented a paper in the poster session of Pharmacoepidemiology / Pharmacoeconomics entitled
"Study on trends of drug use by private practitioners in a town in India and its impact on treatment
cost" which was appreciated by the participants.
Pharmacists are essential participants of the health care team and the field of drugs and pharmaceuticals
who can work in this area to reach medicines of proper quality, proper amount, at proper time for
different clinical conditions to the general mass. My presentation is a humble contribution to the global
research to reach medicines to the underprivileged.
An exhibition was organized during 3 rd - 6 th September 2007. Several exhibitors participated from different
countries around the globe. It was revealed that China has an integrated system of health care system,
which was reported by the exhibitors of Chinese manufacturers of both modern and traditional systems
of medicine. Some exhibitors displayed their products like-Transdermal Patch, which involves highest
modern technology, whereas some have displayed products of traditional system of medicines. A trend
is interesting, which is that they are continuously modernizing their TCM based on scientific approach.
It was worthy to visit that State Food & Drugs Administration (SFDA) of People's Republic of China
exhibited mobile Laboratories having modern facilities including HPLC, IR spectrophotometer. They
reported that they go to remote places of the country and test drug samples on the spot to check
counterfeit drugs. Three hundred and fifty three Mobile Labs were deployed by SFDA in 28 provinces
during February 2006 to August 2007. This measure reflected results in checking counterfeit medicines
and is extremely appreciable.
Outcome:
1. This occasion gave an opportunity to know a large number of facets of the pharmacy profession. I
came to know the actual status of Pharmacy Practice throughout the globe, which has helped me
to realize how to take suitable measures for the development of community pharmacy of our country
in proper direction.
9
Annual Report
200 7
8

10
Annual Report
200 7
8
2. During the six days, I have attended several sessions including GMP, Validation, GCP, Regulatory
affairs, Biotechnology, Clinical research, Community pharmacy, Individualised Medicines etc.,
which have enriched my knowledge and understanding in these areas - which have to be dealt with
during our day-to-day work.
3. This knowledge could be inculcated amongst our colleagues for overall improvement of working
environment of the directorate.
4. My presentation is a humble contribution to the global research to reach medicines to the
underprivileged.
Finally I wish to keep on record that FIP Foundation for Education and Research is an excellent initiative,
which can help a Pharmacist/Pharmaceutical Scientist to avail this opportunity so that they can serve
the profession more efficiently, by attending such conferences, getting to know about the types of
research activities and applied sciences in the pharmaceutical technology sphere through interaction
with participants.
Report on participation at 67th International Congress of FIP, Beijing, China 2007
By
SMDK Ganga Senarathna
2007 FIP Congress Travel Grant Awardee
I attended the 67 th FIP congress with the hope of achieving two objectives 1) To enhance my knowledge
in the field of Academic Pharmacy and 2) To expand my knowledge in evidence based selection of
medicines, pharmacoepidemiology and pharmacoeconomics.
The 67 th FIP congress was equipped with four sessions from Academic Pharmacy section. I attended
all academic pharmacy sessions, two administrative pharmacy sessions and one of pharmacy information
session. I found all the sessions very rewarding.
The session on "Life-long learning and continuing professional development: we have all heard the
theory, what is the evidence?" had three very informative presentations. The presentations were focused
to address the issues related to Continuous Education (CE) and Continuous Professional Development
(CPD) programs and highlighted the difference between the CE and CPD and why it should be CPD
rather than CE. Dr Jennifer Marriot's presentation highlighted certain barriers in conducting CPD
programs and Ms Jennifer Archer's presentation was thought provoking as it pointed out that we might
be conducting CE assuming that it is CPD.
The Pharmaceutical Society of Sri Lanka (PSSL) is conducting a CPD program for the pharmacists in
Sri Lanka even though CPD is not mandatory for practicing pharmacists in Sri Lanka. After this exposure
I joined the sub-committee for CPD at the PSSL, so the knowledge obtained through this session could
be implemented which would help the PSSL to conduct CPD programs more effectively.
The session on "Experiential learning - bridging classroom education and pharmacy practice" was a
totally new concept to me. This session again was very informative and helped us to understand the
importance of experiential learning and the merits of it. At present in my University we have a curriculum
for B.Pharm. course with zero credits for experiential learning and it is not a compulsory requirement.

Having participated in this session, I learned the potential gains of experiential learning and the value
it could add to the pharmacy education. It was also very interesting to listen to Dr Marriot again and
to find out the university courses available to educate trainers of trainee/preceptor education. Mr Mike
Rouse's presentation showed the weight that the US accreditation body has given to experiential learning.
This session proved to me that we have a long way to go both in terms of preceptors and incorporation
of experiential learning into the curriculum. It would be my obligation to suggest incorporation of
experiential learning as a part of the curriculum when the time comes for a curriculum revision and
to identify proper preceptor for educating students. I would acknowledge the FIP foundation for
Education and Research for giving me an opportunity to contribute for curriculum revision.
The session on "Evidence based practice and complementary medicine: teaching and learning by
example" helped me to achieve a major part of my second objective. The two speakers, Ms Kristie
Galbraith and Mr Greg Duncan did a wonderful job of showing how we can answer a clinical question
after critical appraisal of literature. The speakers were very clear on the tools and strategies for searching
the literature and it was interesting to know that a slightly outdated Cochrane review can give an
unsatisfactory answer to the clinical question. The session was useful and it would definitely help me
in future for evidence based selection of medicine and be an evidence based pharmacy practitioner.
The session on "Medication reviews - beyond medication counseling towards service delivery" was an
eye opener to see the services which can be extended at the community pharmacy level. The presentation
by Ms Lea Tuomainen was interesting and it was good to get to know that there are university courses
conducted purely on how to conduct medication reviews for community pharmacists.
To my disappointment, the interest group of the pharmacoepidemiology and pharmacoeconomics did
not meet. However I managed to meet Professor Alan Lyles, Professor Marina Altagracia Martinez and
Professor Albert I. Wertheimer who are also resourced persons in the area of pharmacoeconomics and
discussed some of my research questions with them. It was nice of Professor Martinez for offering to
help me in the future in my pharmacoeconomic studies and I am now in contact with her.
The poster sessions also were very rewarding. I presented a poster and acknowledged FIP foundation
for Education and Research.
I attended the first timer's reception and got exposed to different sections of the FIP foundation and
now I plan to be a member of Academic Pharmacy and Pharmacy Information sections. I also came
to know the activities and benefits of the International Pharmaceutical Students' Federation (IPSF).
Now I am in the process of trying to make our students members of the IPSF.
The congress also allowed me to get to know pharmacists from South East Asia Region and now I can
have better collaboration with them.
The welcome reception at the Great Peoples Hall was an event for a life time. I attended receptions by
the president and by the Chinese Pharmaceutical Association. Further we managed to visit the Great
Wall, Forbidden City and Tiananmen Square and it was a memorable experience.
All in all, attending the 67th FIP congress was a life time experience to me. I gained knowledge,
exposure and I met resourced person from all around the world.
11
200 Annual Report
7
8

12
200 Annual Report
7
8
I shared my experiences with my fellow academic pharmacists, council members of the PSSL and with
our students. I have acknowledged the FIP foundation for Education and Research in all these instances.
I wrote to the Faculty Board in the Faculty of Medical Sciences, University of Sri Jaywardenepura and
included in my progress report to the Research and Higher Degree Committee of Faculty of Medicine,
University of Colombo and acknowledged the receipt of the travel grant from the FIP foundation for
Education and research.
Finally I am extremely grateful to the FIP foundation for Education and Research for giving me the
privilege as one of the recipient of the 2007 FIP travel grant to China. I would have never been there
without your generous funding.
I do pledge that the knowledge and the experience I gained will be used to improve the profession of
Pharmacy in Sri Lanka.
Report on participation at 67th International Congress of FIP, Beijing, China 2007
By
Syed Shamim Raza, Pakistan
2007 FIP Congress Travel Grant Awardee
Attending the International Congresses organized by FIP every year is a unique learning experience
for me. The Beijing conference was my third FIP conference and my second as a FIP Foundation travel
scholarship recipient (the first was Sydney, 2003). Traveling to Beijing was more than a pure scientific
and professional experience for me. Besides achieving most of my expected learning objectives, I met
some renowned researchers, professionals and academics. It was also fascinating to attend the opening
ceremony held at the Great People's Hall and also attend the Goodbye Dinner at the Great Wall, one
of the world's wonders.
On Sunday, September 2 from 0900 - 1230 I attended the forum for innovators in pharmacy practice.
Alison Roberts from the University of Sydney was impressive; the Danish experience was also good.
I also attended the FIP/IPSF Students' day, with the theme of social dimensions of developing the pharmacy
profession. My friend Billy Futter of Rhodess University was superb and Tana Wuliji was also impressive.
Overall it was an exceptionally well attended and good program.
At night I enjoyed the welcome party held at courtyard of Jiuhua Spa & Resort Hotel. The food was
good and music band was awesome. The party ended late night with lots of fun and dance, the
atmosphere was really informal and people were mingling around with each other. I met with Indian
and some South Africans friends.
On September 04 I attended session on clinical trials in Asia organized by FIP Hospital Pharmacy
Section and FIP Industrial Pharmacy Section. It was a very good learning experience for me as I am
looking after the clinical trials in my department and am also a member of my hospital ERC/IRB. In
the afternoon I attended the session held on services and benefits that pharmacists are offering to
society and describing the value of pharmacists. The theme of the program was Is there enough evidence
for the value of pharmacists? Attending the session I learnt that in developing countries like Pakistan

we have to raise the bar, as here the whole pharmacy profession is in infancy and we need to capitalize
on services which save lives and money of patients through pharmacists' interventions.
The 5th September was the busiest day for me right from its beginning until the end as I placed my
poster in the poster area then I attended the session co-sponsored by WHO on technical, scientific and
evidence-based information resources about medicines. I returned to the poster area to find lots of
participants asking questions regarding my work and my hospital. They were amazed to know the
services which we are providing to Pakistani people and were impressed to know that my hospital
received JCIA accreditation - the first hospital in Pakistan to have this international accreditation.
I also went to visit the Chinese hospital and in the afternoon and attended short oral presentations
arranged by the IP community pharmacy section.
On the same day I went to attend Hospital Pharmacy Section dinner at Summer Palace Beijing it was
really beautiful to watch and dine on traditional Chinese cuisines
Medication errors are no doubt an issue in my daily professional life and before hearing John Santell
from United States Pharmacopeia, USA, I had never appreciated the role of a regulatory agency in
preventing them. Mr. Nick Barber's presentation was also good and highlighted issues in lieu of patient
safety, particularly in the context of hospital pharmacy. I must give credit to FIP on arranging a session
on the use of informatics to improve medication safety. My suggestion is to include more in terms of
patient safety in coming the Basel or Istanbul conferences as far as look-alike and sound-alike medications
errors and role of regulatory bodies.
At the Goodbye Dinner Party at the Great Wall I was a full of adrenaline when I found myself in front
of a gigantic and impressive piece of architecture and one of the greatest wonders of the world and a
UNESCO world heritage site. I climbed to the top with other participants and got a certificate on top
that proved that I CLIMBED GREAT WALL ON SEP 06, 2007.
Learning Objectives Achieved:
It is very hard to summarize what I had gained from this congress; however I would like to mention
following objectives that I had achieved:
? I presented my research to the rest of the world to seek their comments, criticism, suggestions and
directions for my future research.
? I gained international exposure and met some of the most senior academics and professionals.
? I learnt some of the useful ways of delivering pharmaceutical services, especially pharmacist's
participation in chronic medical illnesses so that I can create some innovations in my own settings.
? I learnt the way we should present our research, analyze papers, how to criticize any research and
how to tackle questions in an efficient manner.
13
200 Annual Report
7
8

14
200 Annual Report
7
8
? I am extremely motivated to participate in national and international research related to pharmacy
practice and exchange contact information with those who have similar interests as me.
? In short, I would like to say that I had gained a lot in terms of professional competence, selfconfidence,
and vision of future and training of fellow pharmacist to further enhance my professional
capabilities.
I would like to thank FIP Foundation for this travel Scholarship thus making it possible for me to attend
the International event of Pharmacy.
Report on participation at 67th International Congress of FIP, Beijing, China 2007
By
Jocelyn Chaibva, Zimbabwe
2007 FIP Congress Travel Grant Awardee
I felt greatly honoured and humbled to be awarded the FIP Travel grant for 2007, which enabled me
to travel to Beijing China, for the 2007 FIP Congress.
At this Congress, I met many pharmacists from different countries and learnt from their experiences
based on the presentations from the various speakers. The conference presents an opportunity for
pharmacy education in the various areas of pharmacy practice. This was a great learning experience
which is an asset to pharmacy practice in my country of Zimbabwe.
Sessions attended:
During the Congress I attended the following presentations:
Community pharmacy
The responsibility of the community pharmacist to support adherence - How is it done?
This becomes quite tricky in a busy community pharmacy with say, one pharmacist. Within the short
time available, the pharmacist should be able to give simple, yet very important information. This becomes
quite important in the use of steroids, inhalers and in the management of hypertension and diabetes.
Industrial Pharmacy
I attended a workshop on Industrial Pharmacy to familiarize myself with this area of pharmacy practice.
After the Congress in China, we have invited pharmacists in industry to present papers on generic
manufacturing to members of the Pharmaceutical Society of Zimbabwe. The use of generic medicines
is an important topic in resource-limited settings like ours, and good manufacturing practice has to
be maintained.
Academic Section
The symposium on Life Long Learning and Continuing Professional Development was very interesting for
me. I could identify with the issues raised and benefited from the presentations. The barriers to
pharmacists taking CPD are also faced in Zimbabwe. The introduction of CE/CPD as prerequisite for

enewal of practicing certificate found a large number of pharmacists joining the Pharmaceutical Society
of Zimbabwe, which is the main provider of CE for pharmacists. I noted from the presentations that
there is a need for accreditation of CPD providers, so as to ensure that the education provided is relevant
to the profession. Treatment regimes and protocols have been changing over the years, hence the need
for life long learning and CPD.
Counterfeit medicines
This an area which is the subject of campaign programs in various countries. On World Health Day
2007, the Pharmaceutical Society of Zimbabwe participated in a public awareness campaign on the
dangers of unregistered medicines which are obtained from flea markets and other unregistered
premises. It was interesting to note that various stakeholders are working really hard to minimize the
distribution of counterfeit medicines in the various countries.
FIP Pharmacy Information
Reducing antimicrobial resistance is a very pertinent topic which highlighted the need for correct medication
intake. It highlights the results of poor adherence to ARV regimes, which would result in serious drug
resistance and high treatment failure. Second-line treatment becomes unaffordable, especially in
resource-limited settings.
Medication errors recording systems is another area which was of interest to me. Errors can originate
from the doctor, pharmacist or the patient. The need for adequate labeling and effective communication
can not be over-emphasized. This also highlights the need for empowering the patient 'correctly',
especially where online information is concerned, and also the role of the pharmacist in minimizing
the risk of improper medicine use. It has been noted from certain research that the proportion of
medicine errors can be as high 40%!
The campaign on adherence code named "Only the Medicine You Take Will Help" highlights the need
for patient education on adherence, and the role of pharmacists in patient education. This can also be
used as a theme for Pharmacy Day.
African Pharmaceutical Forum
I attended the session of the APF whose objective is to promote pharmacy services is the African region.
I noted that as a region we have not been very active. The forum managed to produce malaria fact cards
and bilharzia fact cards which are tools which can be used for public campaign against malaria and
bilharzia respectively.
I was unable to attend the session on migration of pharmacists, which I know is a serious problem in
my country. The session was held before my arrival in Beijing. I noted from the reports that the problem
is not limited to developing countries only, but is a global issue. In Zimbabwe, there is a School of
Pharmacy with an output on an annual basis. Despite this output, the number of pharmacists in the
public sector is very small, resulting in the use of non-pharmacists doing the pharmacist job in our
public institutions. The Health Ministry is looking at ways of retaining pharmacist in the public sector
in order to strengthen the provision of good pharmaceutical services in the country.
Acknowledgement
My most sincere gratitude goes to the FIP Foundation for affording me an opportunity of a lifetime.
I attended the FIP Congress for the first time, after which I then joined FIP as an individual member.
15
200 Annual Report
7
8

16
200 Annual Report
7
8
I look forward to attending future FIP Congresses, in Basel in 2008 and Turkey in 2009. The Congress
in Beijing China was worth attending. Thanks to FIP Education and Research Foundation for making
it possible for me to attend FIP Congress 2007
2007 Travel Grant Award Winner Jocelyn Chaibva at the Registration Area in Beijing

Medicines
Information to
Children and
their Carers
The recipient of the 2006 Young Pharmacists Professional Innovation award was Dr Rebekah Moles
from Australia.
Rebekah was awarded 1000 Euros to commence a project to develop medication education packages
for children and their carers. Below is an update of the ongoing research which was seeded by the FIP
innovation award.
Background
Use of medicines in children is high. The Australian National Health Survey indicates that 42% of
children under 15 used medications within a two week period prior to survey (National Health survey
2004-5). Previous studies indicate that problems in medicating children are common (Sepponen et al.
2002, Kairuz et al. 2007), however more information is needed on the nature and extent of the problems
of medicine use in children in general. Further, to be able to use medicines correctly, parents need
information. There are numerous sources of information, the reliability of which greatly vary. Pharmacists
are an underused source of reliable and easily reachable information. Research shows that the most
important health information sources for children are parents, especially the mother (Chambers et al.
1997, Menacker et al. 1999, Hämeen-Anttila et al. 2005). However, there are no studies on what
information sources parents use when medicating their children, and furthermore, how they evaluate
the reliability of this information. There is also a lack of knowledge on attitudes of parents when
medicating their children.
Aims of the study
The aim of this research is to explore current trends in children's medicine use.
More specifically, the objectives are to explore:
? how common medicine use is among children under 15 years
? what medicines are commonly used
? for which illnesses and symptoms children use OTC-medicines and prescription medicines
? what kind of problems parents face when medicating their children
? what sources parents use in finding information about medicines
17
200 Annual Report
7
8

18
200 Annual Report
7
8
? what kind of perceptions and attitudes parents have about medicines
? how parents' own medicine use and attitudes influence children's medicine use
? from which sources parents search for information concerning child's medicine use
? which information sources are considered reliable by parents
Materials and methods
The study progresses in three phases
1) Pilot study (PHASE ONE)
The Children's medicine use questionnaire (CMUQ), developed in Finland was pilot tested among
Australian parents. The questionnaire was translated from Finnish to English then back-translated to
ensure semantic equivalence of the English questionnaire to the Finnish version. A total of 153
parents/main caregiver of a child aged 0-15 years were recruited via convenience sampling. Construct
validity of the attitudinal section of the CMQ was performed using exploratory factor analysis. To test
the reliability of statements contained in the instrument, the internal consistency was assessed using
Cronbach's alpha coefficient.
2) Focus groups (PHASE TWO)
Focus group discussions (FGD) with parents of different aged children under 15 years were conducted.
Three focus groups were conducted to explore participants' attitudes towards medicating children and
to triangulate quantitative data.
3) National survey (PHASE THREE)
This phase will use the validated instrument to survey a national sample. This data will inform the
design of education packages for children and their carers.
Results (Phase 1 and 2)
Factor analysis generated a parsimonious four factor solution explaining 50% of variance in the data.
The four subscales representing the four factor solution each returned a Cronbach's Alpha coefficient
> 0.6, indicating good internal consistency. Participants in focus groups were satisfied with the structure
and content of the questionnaire. There were five themes that emerged from focus groups regarding
the perception of medicines use in children. These included: concerns about the negative effects of
medicines, the necessity of prescription medicines for treating illness, the sufficiency of the body's
natural process in fighting illness, the efficacy of over-the-counter medicines, and the use of alternative
medicines in children. Interestingly, most themes discussed in the focus groups were reflected in the
factor solutions.
Implications for further studies and pharmacy practice
The findings of this study to date have shown that the CMQ is a valid and reliable instrument. Small

changes have been made based on focus group feedback and the CMUQ is currently being re-piloted
prior to the national study. The data collected will be used for developing targeted medicine related
educative materials for parents and children. Similar methodology is planned to be used in other
countries. If comparisons across countries show similar results then education packages can be developed
for use in several different settings.
Conclusion
This research is an exciting area where pharmacists have an integral role in supporting children's and
their carer's medication and health education needs. This preliminary exploration into parental views
of medication related issues is an essential first step in order to develop specific and targeted educational
materials for pharmacists and other professionals to use in the future.
19
200 Annual Report
7
8

20
Annual Report
200 7
8
Foundation
Supporters' Club
Donations and other forms of sponsorship are an essential component in the success of the Awards
Programme and the FIP Foundation.
The Foundation has established a series of benefits, both individual and corporate, in order to attract
potential donors/sponsors. Six categories have been installed:
? Ribbon - 25 Euros
? Bronze - 250 Euros
? Silver - 251 – 1,000 Euros
? Gold - 1,001 – 5,000 Euros
? Platinum - 5,001 – 25,000 Euros
? Diamond - 25,001 Euros and more
We would like to highlight the Gold and Diamond categories.
Gold Category:
Dr J.A. Oddis, USA
Prof. K. K. Midha, Canada
Platinum Category:
--
Diamond Category:
Taiwan Society of Health Systems Pharmacists, China Taiwan
The members of the bronze and silver category have received a letter of appreciation after the FIP
Congress, whereas the members of the Gold, Platinum and Diamond categories will be receiving a
certificate of merit and will be personally acknowledged during the Council dinner, which is held at
the FIP World Congress of Pharmacy and Pharmaceutical Sciences in Basel, Switzerland.

ASSETS
Finance
Statement of Income and Expenditure
for the Year Ended December 31 st, 2007
(Expressed in EUR)
2007 2006
Financial fixed assets
Bonds 1 64 688 75 000
Current assets
Prepayments and accrued income 1 2 651 2 471
Cash and Bank 1 333 137 377 278
Total current assets 335 788 379 749
Total assets 400 476 454 749
CAPITAL AND RESERVES AND LIABILITIES
Capital and reserves 345 701 356 976
Allocated funds for future projects 2 30 213 50 508
375 914 397 112
Current account FIP 21 000 35 483
Liabilities grants 3 1 000 1 250
Other liabilities 3 2 562 20 904
Total current liabilities 24 562 57 637
Total capital and reserves and liabilities 400 476 454 749
21
Annual Report
200 7
8

22
Annual Report
200 7
8
INCOME
Statement of Income and Expenditure
for the Year Ended December 31 st, 2007
(Expressed in EUR)
2007 2006
Donations 4 49 360 121 459
Development Grant FIP 25 000 5 000
TOTAL INCOME 74 360 126 459
EXPENSES
Grants 5 20 900 23 380
Operational costs 6 9 449 9 588
Costs allocated funds 6 65 107 136 993
TOTAL EXPENSES 95 456 169 961
OPERATING RESULT 21 096 43 502
Interest 7 102 9 606
FINANCIAL RESULT 102 9 606
NET RESULT BEFORE APPROPRIATION 21 198 33 896
APPROPRIATION OF THE RESULT, (FROM)/TO:
Allocated funds 20 295 23 524
FIP Foundation Capital 903 10 372
TOTAL APPROPRIATED 21 198 33 896

Information
For a copy of the guidelines and/or for further information, please contact the FIP Foundation for
Education and Research, P.O. Box 84200, 2508 AE The Hague, The Netherlands. Telephone number:
+31 70 302 1970 or +31 70 302 1971; fax number: +31 70 302 1999 or E-mail: foundation@fip.org.
23
200 Annual Report
7
8

24
Annual Report
200 7
8

FIP Foundation for Education and Research
Street Address:
Andries Bickerweg 5
2517 JP The Hague
The Netherlands
Mailing address:
P.O. Box 84200
2508 AE The Hague
The Netherlands
Tel.: +31-70-3021970 · Fax: +31-70-3021999
E-mail: foundation@fip.org